|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | ||||||||
| Accounts receivable, net | ||||||||
| Due from former owners | ||||||||
| Inventory | ||||||||
| Refundable income tax | ||||||||
| Investments – equity securities | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Restricted cash - non-current | ||||||||
| Property and equipment, net | ||||||||
| Right-of-use assets | ||||||||
| Intangibles assets | ||||||||
| Goodwill | ||||||||
| Deferred financing costs | ||||||||
| Other assets | ||||||||
| Total assets | ||||||||
| Liabilities and Stockholder’s Deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Accrued expenses | ||||||||
| Cumulative Series A preferred stock dividends payable | ||||||||
| Operating lease liabilities | ||||||||
| Loan payable, net of discount | ||||||||
| Loans payable, net of discount | ||||||||
| Convertible debentures, net of issuance costs | ||||||||
| Convertible notes payable | ||||||||
| Promissory note | ||||||||
| Notes payable, net of discount | ||||||||
| Total current liabilities | ||||||||
| Operating lease liabilities, non-current | ||||||||
| Notes payable - noncurrent | ||||||||
| Total liabilities | ||||||||
| Stockholder’s Equity (Deficit) | ||||||||
| Common stock value | ||||||||
| Class A Common Stock | ||||||||
| Class B Common Stock | ||||||||
| Preferred stock value | ||||||||
| Additional paid in capital | ||||||||
| Accumulated deficit | ||||||||
| Total stockholder’s equity (deficit) | ||||||||
| Total liabilities and stockholder’s equity (deficit) |
Loading...
